医学博士，主治医师，毕业于北京协和医学院北京协和医院，擅长胃肠肿瘤的临床诊疗工作，同时从事胃肠肿瘤化疗耐药、肿瘤转移等相关临床基础研究。设计并实施回顾性以及前瞻性临床研究各1项，以第一或共同第一作者发表论文9篇，其中SCI论文5篇、中文核心期刊论文2篇。主持2项院校基金，参与多项国家自然科学基金，多次参与全国胃癌学术会议、中国外科周、国际外科医师、胃肠病学家和肿瘤学家协会（IASGO）年会、欧洲神经内分泌肿瘤年会、韩国医学肿瘤学会年会等国内国际会议进行科研成果展示。

发表论文

1.戴红梅，等. 基于倾向性评分匹配的食管胃结合部腺癌不同综合治疗模式的单中心回顾性研究. 中华外科杂志; 2022; 60(9):846-852.

2.Hongmei Dai, et al. Notch signaling inhibitor and anti-PD-L1 antibody combination therapies decelerate tumor progression in pancreatic cancer. Journal of Pancreatology; 2021, 4(2): 106-114. 

3.Hongmei Dai#, Hao Chen#, et al. Early detection of cognitive impairment in patients with insulinoma. Endocrine; 2019, 65(3):524-30. 

4.戴红梅,等. 主动脉旁淋巴结转移对胰腺癌可切除性影响的研究进展.中华外科杂志; 2019, 57(1)：68-71.

5.Hongmei Dai#, Xianze Wang#,, et al. Overexpression of catechol-O-methyltransferase occurs early in the progression of pancreatic cancer. Journal of Pancreatology; 2018, 1(1): 39-44. 

6.Chen Lin#, Hongmei Dai#, et al. The prognostic impact of primary tumor resection in pancreatic neuroendocrine tumors with synchronous multifocal liver metastases. Pancreatology; 2018, 18(5): 608-614.

7.Mei Liang#, Jialin Jiang#, Hongmei Dai#, et al. Robotic enucleation for pediatric insulinoma with MEN1 syndrome: a case report and literature review. BMC surgery; 2018, 18(1): 44. 

8.Hongmei Dai, et al. Surgery in Overweight Patients with Insulinoma: Effects on Weight Loss. Scandinavian Journal of Gastroenterology, 2017, 52(9): 1037-1041.

9.Hongmei Dai, et al. Pancreatic neuroendocrine tumor cancer stem cells: Potential novel therapeutic targets? Translational Cancer Research, 2016, 5(6): 860-870.